Improved immunoradiometric assay for plasma renin

Clinical Chemistry

Volumn 45, Issue 6 I, 1999, Pages 847-854

  Deinum, Jaap ^a   Derkx, Frans H M ^a   Schalekamp, Maarten A D H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; ENALAPRIL; RENIN; RENIN INHIBITOR;

ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME KINETICS; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; IMMUNORADIOMETRIC ASSAY; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0033035083     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.6.847     Document Type: Article

References (25)

1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1995:1763-96.
2. Racz K, Pinet F, Gasc JM, Guyenne TT, Corvol P. Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal gland. J Clin Endocrinol Metab 1992;75:730-7.
3. Itskovitz J, Sealey JE, Glorioso N, Rosenwaks Z. Plasma prorenin response to hCG in ovarian hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations. Proc Natl Acad Sci U S A 1987;84:7285-9.
4. Sealey JE, Goldstein M, Pitarresi T, Kudlak TT, Glorioso N, Flamengo SA, et al. Prorenin secretion from human testis: no evidence for secretion of active renin or angiotensinogen. J Clin Endocrinol Metab 1992;75:730-7.
5. Poisner AM, Dowing GJ, Poisner R. Prorenin secretion from villous placenta: regulation by cyclic AMP and angiotensin. Placenta 1994;15:487-99.
6. Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M. Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradiometric assay. J Clin Investig 1989;83: 679-87.
7. Derkx FHM, de Bruin RJA, van Gool JMG, van den Hoek M-J, Beerendonk CCM, Rosmalen F, et al. Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clin Chem 1996;42:1051-63.
8. Sealey JE, Laragh JH. Renin and prorenin: advances and declines in methodology [Editorial]. Clin Chem 1996;42:993-4.
9. Derkx FHM, Schalekamp MADH. More on renin [Letter]. Clin Chem 1997;43:694-5.
10. Sealey JE, Catanzaro D, Laragh JH. More on renin [Reply to Letter to the Editor]. Clin Chem 1997;43:695-7.
11. Osmond DH, Cooper RM. Cryoactivation and tryptic activation of blood prorenin in normal man and animals. Can J Physiol Pharmacol 1978;56:792-805.
12. Pitarresi TM, Rubattu S, Heinrikson R, Sealey JE. Reversible cryoactivation of recombinant human prorenin. J Biol Chem 1992; 267:11753-9.
13. Heusser CH, Bews JPA, Alkan SS, Dietrich FM, Wood JM, de Gasparo M, et al. Monoclonal antibodies to human renin; properties and applications. Clin Exp Hypertens 1987;A9:1259-75.
14. Deinum J, Derkx FHM, Schalekamp MADH. Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation. Biochim Biophys Acta 1998;1388:386-96.
15. Odell WD, Griffin J, Zahradnik R. Two-monoclonal-antibody sandwich-type assay for thyrotropin, with use of an avidin-biotin separation technique. Clin Chem 1986;32:1873-8.
16. Bangham R, Robertson I, Robertson JIS, Robinson CJ, Tree M. An international collaborative study of renin assay: establishment of the International Reference Preparation of human renin. Clin Sci Mol Med 1975;48:135S-59S.
17. Fischli W, Clozel J-P, El Amrani K, Wostl W, Neidhart W, Stadler H, et al. Ro 4205892 is a potent orally active renin inhibitor in primates. Hypertension 1991;18:22-31.
18. Skinner SL, Dunn JR, Mazzetti J, Campbell DJ, Fidge NH. Purification, properties and kinetics of sheep and human renin substrates. Aust J Exp Biol Med Sci 1975;53:77-88.
19. Derkx FHM, Deinum J, Lipovski M, Verhaar M, Fischli W, Schalekamp MADH. Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody. J Biol Chem 1992;267:22837-42.
20. Derkx FHM, Tan-Tjiong HL, Wenting GJ, Boomsma F, Man in 't Veld AJ, Schalekamp MADH. Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension 1983;5:244-56.
21. Derkx FHM, Stuenkel C, Schalekamp MPA, Visser W, Huisveld IH, Schalekamp MADH. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 1986;63:1008-15.
22. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990; 15:44-55.
23. Sealey JE. Plasma renin activity and plasma prorenin assay. Clin Chem 1991;37:1811-9.
24. Hsueh WA, Baxter JD. Human prorenin. Hypertension 1991;17: 469-79.
25. Szecsi PB. The aspartic proteases. Scand J Clin Lab Investig Suppl 1992;210:5-22.